NTRK1 and colorectal carcinoma: Strengths of our study included the use of real-life diagnostic tissue material originating from a cohort of over two thousand consecutive surgically treated primary CRC patients and the use of multiple techniques, including detection of the NTRK1 fusions using three independent RNA–based NGS platforms.